Journal article
A Randomized, Triple-Blind, Placebo-Controlled Trial of Prophylactic Oral Phenobarbital to Reduce the Need for Phototherapy in G6PD-Deficient Neonates
Abstract
OBJECTIVE:Decreased conjugation is probably more important than hemolysis for causing jaundice in G6PD-deficient neonates. The role of enzyme inducers, like phenobarbital, in G6PD deficiency is unclear. This randomized controlled trial was performed to evaluate Phenobarbital's role in reducing the need for phototherapy among G6PD-deficient neonates.STUDY DESIGN:This stratified, randomized, triple-blinded, placebo-controlled trial was conducted …
Authors
Murki S; Dutta S; Narang A; Sarkar U; Garewal G
Journal
Journal of Perinatology, Vol. 25, No. 5, pp. 325–330
Publisher
Springer Nature
Publication Date
May 1, 2005
DOI
10.1038/sj.jp.7211258
ISSN
0743-8346
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, OralCritical CareDouble-Blind MethodFemaleFollow-Up StudiesGestational AgeGlucosephosphate Dehydrogenase DeficiencyHealth Services Needs and DemandHumansInfant, Low Birth WeightInfant, NewbornInfant, PrematureIntensive Care Units, NeonatalJaundice, NeonatalMalePhenobarbitalPhototherapyProbabilityReference ValuesRisk AssessmentStatistics, NonparametricTreatment Outcome